Tessari Eben's Transactions in Kiniksa Pharmaceuticals Shares

Tessari Eben, the Chief Operating Officer of Kiniksa Pharmaceuticals International, plc, reported several transactions involving the company's Class A Ordinary Shares. On July 15, 2025, Eben acquired 752 shares at $15.63 per share under the company's 2018 Employee Share Purchase Plan. On August 5, 2025, Eben exercised multiple share options, acquiring a total of 138,664 shares at various prices. Additionally, Eben sold 138,614 shares at weighted average prices of $33.20 and $33.90 per share. These transactions were executed pursuant to a 10b5-1 plan and were exempt under Rule 16B-3(e). Following these transactions, Eben's total holdings in Kiniksa Pharmaceuticals amounted to 49,915 shares.